These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 24027313)
1. Human astrocytic cells support persistent coxsackievirus B3 infection. Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313 [TBL] [Abstract][Full Text] [Related]
2. Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression. Böhnke J; Pinkert S; Schmidt M; Binder H; Bilz NC; Jung M; Reibetanz U; Beling A; Rujescu D; Claus C Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513663 [TBL] [Abstract][Full Text] [Related]
3. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis. Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827 [TBL] [Abstract][Full Text] [Related]
5. Role of neutrophils in CVB3 infection and viral myocarditis. Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107 [TBL] [Abstract][Full Text] [Related]
6. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions. Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253 [TBL] [Abstract][Full Text] [Related]
7. Transient induction of cytokine production in human myocardial fibroblasts by coxsackievirus B3. Heim A; Zeuke S; Weiss S; Ruschewski W; Grumbach IM Circ Res; 2000 Apr; 86(7):753-9. PubMed ID: 10764408 [TBL] [Abstract][Full Text] [Related]
8. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3. Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846 [TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 Activates Macrophages Independently of CAR-Mediated Viral Entry. Mohamud Y; Lin JC; Hwang SW; Bahreyni A; Wang ZC; Luo H Viruses; 2024 Sep; 16(9):. PubMed ID: 39339932 [TBL] [Abstract][Full Text] [Related]
10. Suppression of proinflammatory cytokines and induction of IL-10 in human monocytes after coxsackievirus B3 infection. Hofmann P; Schmidtke M; Stelzner A; Gemsa D J Med Virol; 2001 Aug; 64(4):487-98. PubMed ID: 11468734 [TBL] [Abstract][Full Text] [Related]
11. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice. Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680 [TBL] [Abstract][Full Text] [Related]
12. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319 [TBL] [Abstract][Full Text] [Related]
13. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas. Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains. Wang Q; Yang Q; Liu C; Wang G; Song H; Shang G; Peng R; Qu X; Liu S; Cui Y; Wang P; Xu W; Zhao X; Qi J; Yang M; Gao GF Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046043 [TBL] [Abstract][Full Text] [Related]
15. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888 [TBL] [Abstract][Full Text] [Related]
16. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. Pinkert S; Klingel K; Lindig V; Dörner A; Zeichhardt H; Spiller OB; Fechner H J Virol; 2011 Dec; 85(24):13409-19. PubMed ID: 21976640 [TBL] [Abstract][Full Text] [Related]
17. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism. Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012 [TBL] [Abstract][Full Text] [Related]
18. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice. Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341 [TBL] [Abstract][Full Text] [Related]
19. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. Yuan J; Yu M; Lin QW; Cao AL; Yu X; Dong JH; Wang JP; Zhang JH; Wang M; Guo HP; Cheng X; Liao YH J Immunol; 2010 Oct; 185(7):4004-10. PubMed ID: 20802148 [TBL] [Abstract][Full Text] [Related]
20. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact. Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]